Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Neuropathol Exp Neurol ; 77(12): 1091-1100, 2018 12 01.
Article in English | MEDLINE | ID: mdl-30299493

ABSTRACT

Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder linked to repetitive head impacts and has been associated with amyotrophic lateral sclerosis (ALS), a fatal, degenerative neuromuscular disorder. The Department of Veterans Affairs Biorepository Brain Bank (VABBB) is a tissue repository that collects antemortem disease progression data and postmortem central nervous system tissue from veterans with ALS. We set out to determine the frequency of co-morbid ALS and CTE in the VABBB cohort and to characterize the clinical, genetic, and pathological distinctions between participants with ALS only and those with both ALS and CTE (ALS+CTE). Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALS+CTE. Participants with ALS+CTE were more likely to have a history of traumatic brain injury (p < 0.001), served during the first Persian Gulf War (p < 0.05), and to have more severe tau pathology within the frontal cortex and spinal cord (p < 0.05). The most common exposures to head impacts included contact sports (n = 5) and military service (n = 2). Clinically, participants with ALS+CTE were more likely to have bulbar onset ALS (p = 0.006), behavioral changes (p = 0.002), and/or mood changes (p < 0.001). Overall, compared with ALS in isolation, comorbid ALS+CTE is associated with a history of TBI and has a distinct clinical and pathological presentation.


Subject(s)
Amyotrophic Lateral Sclerosis/pathology , Brain/pathology , Chronic Traumatic Encephalopathy/pathology , Tissue Banks/trends , United States Department of Veterans Affairs/trends , Adult , Aged , Aged, 80 and over , Amyotrophic Lateral Sclerosis/epidemiology , Amyotrophic Lateral Sclerosis/genetics , Chronic Traumatic Encephalopathy/epidemiology , Chronic Traumatic Encephalopathy/genetics , Cohort Studies , Comorbidity , Female , Humans , Longitudinal Studies , Male , Middle Aged , United States/epidemiology
2.
Emerg Infect Dis ; 23(13)2017 12.
Article in English | MEDLINE | ID: mdl-29155678

ABSTRACT

The Joint External Evaluation (JEE), a consolidation of the World Health Organization (WHO) International Health Regulations 2005 (IHR 2005) Monitoring and Evaluation Framework and the Global Health Security Agenda country assessment tool, is an objective, voluntary, independent peer-to-peer multisectoral assessment of a country's health security preparedness and response capacity across 19 IHR technical areas. WHO approved the standardized JEE tool in February 2016. The JEE process is wholly transparent; countries request a JEE and are encouraged to make its findings public. Donors (e.g., member states, public and private partners, and other public health institutions) can support countries in addressing identified JEE gaps, and implementing country-led national action plans for health security. Through July 2017, 52 JEEs were completed, and 25 more countries were scheduled across WHO's 6 regions. JEEs facilitate progress toward IHR 2005 implementation, thereby building trust and mutual accountability among countries to detect and respond to public health threats.


Subject(s)
Global Health , International Cooperation , Process Assessment, Health Care , Public Health Surveillance , Public Health , Humans , Process Assessment, Health Care/methods , Process Assessment, Health Care/standards , Public Health Surveillance/methods , Quality Assurance, Health Care , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL
...